FridayJun 10, 2022 12:40 pm

QualityStocksNewsBreaks – Flora Growth Corp.’s (NASDAQ: FLGC) Completion of Key Milestones Position It for Success

Flora Growth Corp. (NASDAQ: FLGC) recently announced financial and operating results for the 2021 fiscal year that show the success of its efforts as revenues and profits begin what is expected to be a rapid climb. “The year-end financial results show about $9 million in revenues, which is ‘significantly higher’ than those reported the prior year before the law change and Flora’s IPO launch on the Nasdaq Capital Market. The report maintains the company’s outlook for ending 2022 with revenues of $35 million to $45 million, which would be growth of between 288% and 400% over 2021. Much of Flora’s…

Continue Reading

FridayJun 10, 2022 12:26 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Using Music Technology to Disrupt Record Label Industry

Friendable (OTC: FDBL), in addition to its flagship offering, Fan Pass Live, acquired Artist Republik and FeaturedX to create a 360 platform for independent artists looking to remain in control of their music. “The platform was designed to address what is a glaring problem with the record label industry. On average, artists are losing 90% of their streaming revenue to their label, 10% to booking agents, and 15-20% of their overall income to management. Additionally, many artists who sign with a label feel a lack of support and a massive burden of being controlled by these labels. What might have…

Continue Reading

FridayJun 10, 2022 10:46 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Awarded Board Approval for CYB003 Phase 1/2a Clinical Trial

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, received Institutional Review Board (“IRB”) approval to begin its planned phase 1/2a clinical trial. The trial, the first-in-human phase 1/2a trial evaluating CYBN’s proprietary deuterated psilocybin analog CYB003, is slated to begin in mid-2022.The study will evaluate CYB003 for the treatment of major depressive disorder (“MDD”).  Cybin applied for IRB approval just last month. According to the announcement, Cybin wholly owned subsidiary Cybin IRL Limited has partnered with Clinilabs Drug Development Corporation to conduct the randomized, double-blind, placebo-controlled study. The study involves participants receiving two administrations of…

Continue Reading

ThursdayJun 09, 2022 3:42 pm

QualityStocksNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Leveraging Lightning Network with PaaS Offering

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network (“LN”), is among companies that are not in the “watch and wait” mode when it comes to Bitcoin or the LN. This is despite observers’ expectations that the crypto market will stay in a bear phase for some time. “LQwD is still leveraging the Lightning Network with its platform as a service (‘PaaS’). LQwD launched its PaaS offering lqwd.tech in November 2021, the same time it launched its first node on the Lightning Network in the United States. Since…

Continue Reading

ThursdayJun 09, 2022 3:04 pm

QualityStocksNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR) Inks Licensing, Distribution Deal with Global iGaming Supplier

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR), a propriety SaaS technology company delivering mobile-first live-dealer technology to online gaming operators globally, has signed a software license and distribution agreement with Markor Technology, a global iGaming supplier. Markor Technology has built a reputation for offering products driven by data science and machine-learning automation. The company’s multivertical portfolio includes state-of-the-art iGaming platform (“PAM”), white-label solutions, game aggregation and managed services. According to the three-year agreement, Markor Technology will add Playgon's exclusive, mobile-first Vegas Lounge live dealer and e-table offerings to its content library, where it will be available to a global…

Continue Reading

ThursdayJun 09, 2022 2:54 pm

QualityStocksNewsBreaks – Kronos Advanced Technologies Inc. (KNOS) Continues Transformation to Globally Dominant Consumer Product Design, Manufacturing Company

Kronos Advanced Technologies (OTC: KNOS) recently completed the acquisition of an 85,000-square-foot West Virginia manufacturing campus that will be retrofitted to produce advanced, proprietary air-purification devices and other wellness products. With this move, Kronos is committed to manufacturing completely on American soil. “Nearly two years ago, we set into motion a strategic plan to transform Kronos from a marketing and fulfillment company, positioned within the fragmented market space of air purification, into a globally dominant consumer product design and manufacturing company… This acquisition is a key foundational milestone in our transformation,” a recent article quotes Kronos COO and CTO Joseph…

Continue Reading

ThursdayJun 09, 2022 2:40 pm

QualityStocksNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Engages IBN for Corporate Communications Expertise

Aditxt (NASDAQ: ADTX), a biotech innovation company, today announced that it has selected the corporate communications expertise of IBN (“InvestorBrandNetwork”), a multifaceted financial news and publishing company for private and public entities. As part of the relationship, IBN will leverage its investor based distribution network of 5,000+ key syndication outlets, various newsletters, social media channels, wire services via InvestorWire, blogs, and other outreach tools to generate greater awareness for Aditxt. “The potential market opportunities presented by immune monitoring and reprogramming are extensive. Through its work in the COVID-19 testing market with AditxtScore(TM), Aditxt demonstrated this potential. The company is now…

Continue Reading

ThursdayJun 09, 2022 2:20 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX), Rogue Station Companies Inc./Everdime Inc. (RGST) Enter Partnership to Enhance Investor Communications

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, has entered a partnership with Rogue Station Companies/Everdime (OTC: RGST). Through SRAX, RGST, a crypto and blockchain development company building the technology bridge that connects what is real and the new augmented reality within the metaverse, will have the ability to further reach its community through sophisticated solutions. “The RGST/Everdime team warmly welcomes our recent partnership with SRAX,” said RGST CEO Sandor Miklos. “As our company continues BETA testing its apps and prepares to launch its token and…

Continue Reading

ThursdayJun 09, 2022 2:10 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Portfolio of Rare Cannabinoids with Launch of d9-THCV

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced its launch of B2B sales of the rare cannabinoid delta 9-dominant tetrahydrocannabivarin (“d9-THCV”) into the health and wellness sector via its wholly owned subsidiary, BayMedica LLC. “We are very excited to launch our highly anticipated d9-THCV and further enhance BayMedica’s growing product portfolio,” said Shane Johnson, MD, SVP and general manager of BayMedica. “THCV is one of the few rare cannabinoids that has been researched in early clinical trials for various therapeutic effects, fueling significant interest by end-product manufacturers and consumers alike.…

Continue Reading

ThursdayJun 09, 2022 1:16 pm

QualityStocksNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Announces Approval of NCIB by TSX Venture Exchange

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, today announced that the TSX Venture Exchange (“TSXV”) has approved the company’s Normal Course Issuer Bid (“NCIB”). The NCIB will allow EverGen to purchase issued and outstanding common shares of EverGen through the facilities of the TSXV during a 12 month period, commencing on June 8, 2022, and ending on June 7, 2023, or such earlier date as EverGen may complete its purchases pursuant to the NCIB or as it may otherwise determine. According to the update, the company implemented the NCIB because it believes that, from time…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered